1. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction (Oxford, England). 2016;31(12):2841-55.
2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
3. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews Endocrinology. 2011;7(4):219-31.
4. Le Goascogne C, Sananes N, Gouezou M, Takemori S, Kominami S, Baulieu EE, et al. Immunoreactive cytochrome P-450(17 alpha) in rat and guinea-pig gonads, adrenal glands and brain. Journal of reproduction and fertility. 1991;93(2):609-22.
5. Pelletier G, Li S, Luu-The V, Tremblay Y, Belanger A, Labrie F. Immunoelectron microscopic localization of three key steroidogenic enzymes (cytochrome P450(scc), 3 beta- hydroxysteroid dehydrogenase and cytochrome P450(c17)) in rat adrenal cortex and gonads. The Journal of endocrinology. 2001;171(2):373-83.
6. Nelson VL, Legro RS, Strauss JF, 3rd, McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Molecular endocrinology (Baltimore, Md). 1999;13(6):946-57.
7. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456-88.
8. Liu K, Liu YX, Hu ZY, Zou RY, Chen YJ, Mu XM, et al. Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression. Molecular and cellular endocrinology. 1997;133(2):109-16.
9. Liu YX, Liu XM, Nin LF, Shi L, Chen SR. Serine protease and ovarian paracrine factors in regulation of ovulation. Frontiers in bioscience (Landmark edition). 2013;18:650-64.
10. Yoshimura Y, Maruyama K, Shiraki M, Kawakami S, Fukushima M, Nakamura Y. Prolactin inhibits plasminogen activator activity in the preovulatory follicles. Endocrinology. 1990;126(1):631-6.
11. Devin JK, Johnson JE, Eren M, Gleaves LA, Bradham WS, Bloodworth JR, Jr., et al. Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice. Journal of molecular endocrinology. 2007;39(1):9-16.
12. Mizushima N. Autophagy: process and function. Genes & development. 2007;21(22):2861-73.
13. Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nature cell biology. 2010;12(9):823-30.
14. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27- 42.
15. Gonzalez-Rodriguez A, Mayoral R, Agra N, Valdecantos MP, Pardo V, Miquilena- Colina ME, et al. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell death & disease. 2014;5:e1179.
16. Pinola P, Puukka K, Piltonen TT, Puurunen J, Vanky E, Sundstrom-Poromaa I, et al. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life. Fertil Steril. 2017;107(3):788-95.e2.
17. Rocha ALL, Faria LC, Guimaraes TCM, Moreira GV, Candido AL, Couto CA, et al. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. Journal of endocrinological investigation. 2017.
18. Tajima K, Orisaka M, Hosokawa K, Amsterdam A, Kotsuji F. Effects of ovarian theca cells on apoptosis and proliferation of granulosa cells: changes during bovine follicular maturation. Biology of reproduction. 2002;66(6):1635-9.
19. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nature immunology. 2011;12(5):408-15.
20. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007;131(6):1149-63.
21. Rabieian R, Boshtam M, Zareei M, Kouhpayeh S, Masoudifar A, Mirzaei H. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis. J Cell Biochem. 2018;119(1):17-27.
22. Yoshii SR, Mizushima N. Monitoring and Measuring Autophagy. Int J Mol Sci. 2017;18(9).
23. Pasquier B. Autophagy inhibitors. Cellular and molecular life sciences : CMLS. 2016;73(5):985-1001.
24. Towers CG, Thorburn A. Therapeutic Targeting of ♙utophagy. EBioMedicine. 2016;14:15-23.
25. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3(6):542-5.
26. Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron. 2015;85(2):257-73.
27. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728-41.
28. Wu D, Cederbaum AI. Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK. Redox biology. 2013;1:552-65.
29. Yamamoto T, Takabatake Y, Takahashi A, Kimura T, Namba T, Matsuda J, et al. High- Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney. Journal of the American Society of Nephrology : JASN. 2017;28(5):1534-51.
30. Giang AH, Raymond T, Brookes P, de Mesy Bentley K, Schwarz E, O'Keefe R, et al. Mitochondrial dysfunction and permeability transition in osteosarcoma cells showing the Warburg effect. The Journal of biological chemistry. 2013;288(46):33303-11.
31. Henriksen EJ, Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free radical biology & medicine. 2011;51(5):993-9.
32. Pal M, Febbraio MA, Lancaster GI. The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance. The Journal of physiology. 2016;594(2):267-79.
33. Wu H, Ballantyne CM. Skeletal muscle inflammation and insulin resistance in obesity. The Journal of clinical investigation. 2017;127(1):43-54.
34. Vanholder T, Lmr Leroy J, Van Soom A, Maes D, Coryn M, Fiers T, et al. Effect of non-esterified fatty acids on bovine theca cell steroidogenesis and proliferation in vitro. Animal reproduction science. 2006;92(1-2):51-63.
35. Niu Z, Lin N, Gu R, Sun Y, Feng Y. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. The Journal of clinical endocrinology and metabolism. 2014;99(11):E2269-76.
36. Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, et al. Autophagy- deficient mice develop multiple liver tumors. Genes & development. 2011;25(8):795-800.
37. Qin W, Li C, Zheng W, Guo Q, Zhang Y, Kang M, et al. Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells. Oncotarget. 2015;6(37):39839-54.
38. Wang J, Tan X, Yang Q, Zeng X, Zhou Y, Luo W, et al. Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells. Int J Biochem Cell Biol. 2016;77(Pt A):80-90.
39. Dai Y, Palade P, Wang X, Mercanti F, Ding Z, Dai D, et al. High fat diet causes renal fibrosis in LDLr-null mice through MAPK-NF-kappaB pathway mediated by Ox-LDL. Journal of cardiovascular pharmacology. 2014;63(2):158-66.
40. Solinas G, Becattini B. JNK at the crossroad of obesity, insulin resistance, and cell stress response. Molecular metabolism. 2017;6(2):174-84.
41. Li H, Li D, Ma Z, Qian Z, Kang X, Jin X, et al. Defective autophagy in osteoblasts induces endoplasmic reticulum stress and causes remarkable bone loss. Autophagy. 2018;14(10):1726-41.
42. Ochoa CD, Wu RF, Terada LS. ROS signaling and ER stress in cardiovascular disease. Mol Aspects Med. 2018;63:18-29.
43. Takahashi N, Harada M, Hirota Y, Zhao L, Yoshino O, Urata Y, et al. A potential role of endoplasmic reticulum stress in development of ovarian hyperstimulation syndrome. Molecular and cellular endocrinology. 2016;428:161-9.
44. Takahashi N, Harada M, Hirota Y, Nose E, Azhary JM, Koike H, et al. Activation of Endoplasmic Reticulum Stress in Granulosa Cells from Patients with Polycystic Ovary Syndrome Contributes to Ovarian Fibrosis. Scientific reports. 2017;7(1):10824.
45. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of clinical investigation. 2006;116(11):3015-25.
46. Wang Z, Liu D, Wang F, Liu S, Zhao S, Ling EA, et al. Saturated fatty acids activate microglia via Toll-like receptor 4/NF-kappaB signalling. The British journal of nutrition. 2012;107(2):229-41.